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Regulation and characteristics of vascular
smooth muscle cell phenotypic diversity
Vascular smooth muscle cells can perform both
contractile and synthetic functions, which are
associated with and characterised by changes in
morphology, proliferation and migration rates,
and the expression of different marker proteins.
The resulting phenotypic diversity of smooth
muscle cells appears to be a function of innate
genetic programmes and environmental cues,
which include biochemical factors, extracellular
matrix components, and physical factors such as
stretch and shear stress. Because of the diversity
among smooth muscle cells, blood vessels attain
the flexibility that is necessary to perform efficiently
under different physiological and pathological
conditions. In this review, we discuss recent
literature demonstrating the extent and nature of
smooth muscle cell diversity in the vascular wall
and address the factors that affect smooth muscle
cell phenotype. (Neth Heart J 2007;15:100-8.) 
Keywords: (smooth) (vascular), cell differentiation,
phenotype, diversity, synthetic, contractile
Smooth muscle cells (SMCs) are essential for goodperformance of the vasculature. By contraction
and relaxation, they alter the luminal diameter, which
enables blood vessels to maintain an appropriate blood
pressure. However, vascular SMCs also perform other
functions, which become progressively more important
during vessel remodelling in physiological conditions
such as pregnancy and exercise, or after vascular injury.1
In these cases, SMCs synthesise large amounts of
extracellular matrix (ECM) components and increase
proliferation and migration. Because of these proper-
ties, SMCs are fit not only for short-term regulation
of the vessel diameter, but also for long-term
adaptation, via structural remodelling by changing cell
number and connective tissue composition.
The different functions that SMCs can exert translate
into a diversity of SMC phenotypes, ranging from
contractile to synthetic. The diversity becomes ap-
parent in morphology, expression levels of SMC
marker genes, proliferative potential and migration
properties. These differences are observed between
SMCs of different vessels as well as amongst SMCs
within the same vessel. Part of the variation in SMC
populations can be explained by the diverse embryo-
logical origins of SMCs, reviewed by Gittenberger-de
Groot et al.2 However, the remarkable capability of
SMCs to shuttle between different phenotypes, re-
ferred to as phenotypic modulation,3 may be more
important, as it is superimposed on the origin-related
phenotype. 
The mechanisms by which SMCs acquire a particular
phenotype are the subject of intense research. This
review will focus on the diversity of SMC phenotypes
in the vessel wall and the factors and conditions that
control it. We start with a brief description of the
characteristics of different vascular SMC phenotypes
and discuss the lack of definition of those phenotypes.
Subsequently, the nature of SMC diversity in the vessel
wall will be addressed before describing the factors
and conditions that control it. 
Characteristics of vascular smooth muscle cell
diversity
Contractile and synthetic SMCs, which represent the
two ends of a spectrum of SMCs with intermediate
phenotypes, have clearly different morphologies. Con-
sequently, morphology is still an important parameter
for the definition of SMC phenotypes, although the
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use of marker proteins for this purpose has become
customary. Contractile SMCs are elongated, spindle-
shaped cells, whereas synthetic SMCs are less elongated
and have a cobblestone morphology which is referred
to as epithelioid or rhomboid (figure 1).3,4 Synthetic
SMCs contain a high number of organelles involved
in protein synthesis, whereas these are largely replaced
by contractile filaments in contractile SMCs. Moreover,
synthetic and contractile SMCs have different pro-
liferative and migratory characteristics. Generally,
synthetic SMCs exhibit higher growth rates and higher
migratory activity than contractile SMCs.3
Protein markers of vascular smooth muscle cell
phenotypes
The SMC marker proteins that are commonly used to
define SMC phenotypes have recently been extensively
reviewed.1,5 The markers that are most relevant to this
review (α-smooth muscle actin (α-SMA), smooth
muscle-myosin heavy chain (SM-MHC), smoothelin-
A/B, SMemb/non-muscle MHC isoform-B and
cellular retinol binding protein (CRBP)-1) and some
additional markers that are often used are presented
in table 1. Many of these proteins are involved in SMC
contraction, either as a structural component of the
contractile apparatus or as a regulator of contraction.
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Figure 1. Ultrastructural characteristics of contractile and synthetic
SMCs.
Table 1. Characteristics of widely used SMC marker proteins. 
Marker protein SMC Phenotype Subcellular Onset of Function
specificity specificity localisation expression 
α-smooth muscle actin Embryo - c>s Contractile filaments E9 heart/ Contraction
Adult +/- somites/SMCs 
Smooth muscle-myosin heavy chain Embryo + SM1 c>s Contractile filaments E10.5 SMCs Contraction
Adult + SM2 c
SM22α Embryo - c>s Actin-associated E8 heart/ Regulation contraction
Adult + E9.5 SMCs
SM-calponin Embryo - c>s Actin-associated/ E8.5 heart Regulation contraction/
Adult + cytoskeleton E13.5 SMCs signal transduction
H-caldesmon Embryo + c Actin-associated WK 10 human Regulation contraction
Adult +
Smoothelin Embryo - c Actin-associated E13 Regulation contraction
Adult +
Telokin Embryo+/? c>s Cytoplasmic/ E11.5 gut Regulation contraction
Adult + membrane
Meta-vinculin Embryo - c>s Cytoskeleton WK 24 human Anchoring cell-ECM
Adult -
Desmin Embryo - c>s Cytoskeleton E9.5 myotome Structural mechanical
Adult - integrity
CRBP-1 Embryo - s>c Cytoplasm E10 Retinoid transport and
Adult - metabolism
Smemb Embryo - s>c Contractile filaments ND Contraction
Adult -
Compiled from Owens et al. and Miano.1,5
c=contractile, s=synthetic, E=mouse embryonic day, WK 24=week 24 of human development, ND=not determined.
The expression levels of these contractile marker
proteins gradually decrease when SMCs are cultured,
although the extent to which their expression is down-
regulated differs among the markers.6 Markers that are
upregulated in the synthetic phenotype are rare.
Instead, disappearance of proteins associated with the
contractile phenotype is generally taken as character-
istic of the synthetic phenotype (figure 2). SMCs with
different phenotypes express varying levels of the
marker proteins rather than completely different
marker proteins. Therefore, information on the expres-
sion of at least two proteins that are associated with a
particular phenotype is required to distinguish a
contractile from a synthetic SMC, preferably com-
plemented with data on morphology, proliferation and
migration characteristics.
At present, the two marker proteins that provide the
best definition of a mature contractile SMC phenotype
are SM-MHC and smoothelin. SM-MHC expression
has never been detected in non-SMCs in vivo, and is
the only marker protein that is also SMC specific during
embryogenesis.7 Smoothelin complements SM-MHC
as a contractile SMC marker in that it appears to be
more sensitive. Its expression is more uniformly and
more rapidly downregulated in cultured vascular SMCs
modulating towards a synthetic phenotype.6 Both SM-
MHC and smoothelin have been shown to be absent
in myofibroblasts in models of arterial injury.8
SMemb/non-muscle MHC isoform-B and, in
rodents, CRBP-1 represent suitable synthetic SMC
markers, since these proteins are quickly and markedly
upregulated in proliferating SMCs.9,10 In addition,
changes in ratios of specific splice variants of contractile
proteins (h-caldesmon, meta-vinculin) can be used to
indicate a synthetic phenotype.11
Occurrence of vascular SMC diversity
The nature of SMC diversity in the vessel wall is well
illustrated by immunohistochemical staining patterns
of contractile SMC phenotype markers. These, almost
invariably, reveal highly heterogeneous staining pat-
terns and intensities between adjacent SMCs.6,12 These
differences become more distinct after vascular injury.
Although the overall expression level of contractile
SMC phenotype markers after vascular injury initially
goes down, the response is remarkably heterogeneous
between the different SMCs in the vessel wall.8 Further-
more, re-expression of contractile SMC markers at later
time points does not occur uniformly but, rather, first
in subpopulations of cells.13 More detailed information
on the nature of SMC diversity has been obtained by
analyses of primary cultures.6,14,15 These studies show
that immediately after enzymatic digestion, SMCs
contain not only different amounts of contractile
proteins, but also that some SMCs do not express
particular contractile markers at all. 
Not only contractile SMC marker proteins reflect SMC
diversity in the arterial wall. Gap junctional proteins
and adhesion molecules are also differentially expressed.
A complex differential expression of integrin subunits
in different SMC subsets has been described.16 N-
cadherin and T-cadherin are also differentially ex-
pressed in aortic SMC layers, with higher levels in
SMCs adjacent to endothelial cells. In addition, SMCs
of elastic neural crest derived arteries express
connexin43, in contrast to SMCs of muscular arteries.
Regulation and characteristics of vascular smooth muscle cell phenotypic diversity
102 Netherlands Heart Journal, Volume 15, Number 3, March 2007
Figure 2. Schematic representation of expression levels of genes associated with a particular SMC phenotype. Note that most of the indicated
proteins are not SMC specific. 
The human internal mammary artery, which has both
elastic and muscular segments, shows inversely cor-
related levels of connexin43 and desmin in SMCs of
these different parts.17
The variations between SMCs within a particular vessel,
both with respect to marker gene expression and
functional and morphological characteristics, suggest
that there may be a genetic basis for SMC diversity.
After all, such SMCs share similar embryological origins
and experience comparable local conditions. This con-
cept is substantiated by several studies reporting the
persistence of in vivo phenotypes in culture, despite
changed conditions. For example, within the bovine
pulmonary artery, four SMC phenotypes with distinct
marker protein expression profiles and different mor-
phologies have been described.18 The existence of
distinct SMC populations within the same artery has
also been demonstrated in the rat,14 the pig,6,15 and in
humans.19 In all these studies, in vivo differences were
maintained in vitro. SMCs isolated from the human
internal thoracic artery form a particularly illustrative
example.19 These SMCs were cloned after enzymatic
digestion, producing epithelioid as well as spindle-
shaped cell types. Both had a contractile gene expres-
sion profile, but only spindle-shaped cells expressed
meta-vinculin. They also had higher SM-MHC and
SM-calponin levels and a higher h-caldesmon/l-
caldesmon ratio. Apart from these differences, the two
types of clones differed with respect to proliferation
rate, ECM build-up and responses to various growth
factors and hormones. One typical spindle-shaped
clone, designated HITB5, was able to adopt either a
synthetic or a contractile phenotype, depending on
serum concentrations.20 This shows that even though
SMC phenotypes can be stable in culture, they can also
be manipulated to adopt a certain phenotype, allowing
the study of agents that modulate phenotypes. SMC
clones that are capable of reversible modulation to both
ends of the phenotype spectrum have also been derived
from porcine coronary artery SMCs.15 These cells dis-
played phenotypic modulation after fibroblast growth
factor (FGF)-2 or platelet-derived growth factor
(PDGF)-B treatment or withdrawal. PDGF-B drove
spindle-shaped SMC clones towards the rhomboid
phenotype. Concomitantly, proliferation and migration
increased and SM-MHC and smoothelin expression
greatly diminished.
The studies summarised above indicate that although
SMC phenotype appears to be genetically programmed,
local environmental cues can still modulate the
characteristics of the SMCs. This raises the question of
the relative importance of the local environment versus
genetic programming. An elegant study in which
cultured arterial SMCs with different phenotypes were
implanted into rat carotid arteries provided an in-
dication that genetic programming may be at least as
important as the local environment.21 The implanted
cells, either spindle-shaped cells from newborn rats or
epithelioid cells derived from old rats, retained their
specific expression pattern of α-SMA and SM-MHC
in vivo. Moreover, the epithelioid SMCs maintained
expression of CRBP-1 for at least 20 days. Thus, there
is also in vivo evidence that diversity is an intrinsic
quality of SMCs.
Epigenetic programmes, which differ for various
SMC populations, may determine the extremes of the
phenotype range that a particular SMC can adopt.
Modulation of the phenotype is only possible between
these phenotype boundaries and governed by environ-
mental conditions (figure 3). The challenge for future
studies will be to show in how far these conditions can
lead to genetic reprogramming, thereby shifting the
phenotype boundaries. 
Determinants of vascular SMC diversity
Much progress has been made in recent years concern-
ing the identification of transcription factors that
regulate SMC differentiation and phenotype. The
important roles of serum response factor (SRF) and
its co-activator myocardin in this respect have been re-
cently reviewed1,5 and will not be discussed here.
Relevant to this review is that concentration gradients
and alternatively spliced isoforms of SRF have specific
effects on SMC gene transcription and consequently
may contribute to SMC diversity.22 In addition,
myocardin has a heterogeneous expression pattern in
SMCs of different tissues,23 which may contribute to
variations in marker gene expression and consequently
SMC function. Whereas the transcription factors that
regulate SMC phenotype are more and more defined,
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Figure 3. Whereas the SMCs in a vessel can
collectively cover the whole spectrum of pheno-
types, a given population of SMCs (indicated
by a to f, respectively) can only cover a limited
area of this spectrum. The boundaries of the
spectrum for any given SMC population are
defined by (epi)genetic programmes. SMCs
can modulate their phenotype within the
boundaries, a process which is controlled by
the integration of environmental factors. 
the list of factors that can activate or inhibit them
continues to expand. These factors constitute the local
environmental cues that, within the genetic predis-
position, determine the phenotype of a given SMC.
They are very diverse in nature and include a variety
of soluble biocompounds, ECM proteins, as well as
physical parameters (figure 4). 
Biochemical factors
Many biocompounds have been reported to affect
expression of SMC phenotype markers, some of which
even have phenotype-dependent effects. In this review,
we will focus on a selection of factors that are supported
by a substantial amount of experimental data in this
context. These factors include PDGF, transforming
growth factor (TGF)-β, activin A, retinoids, angio-
tensin II, and tumour necrosis factor-α (TNF-α).
Besides these, compounds such as FGF, insulin-growth
factor (IGF)-I and -II, endothelin-1, nitric oxide (NO),
reactive oxygen species, peroxisome proliferator-
activated receptor-gamma ligands and complement 3
protein have been shown to affect SMC phenotype.
Two PDGF molecules, PDGF-A and PDGF-B, are
important for the initial stages of SMC differentiation
during vascular development, which are characterised
by recruitment of mesenchymal cells and subsequent
proliferation.24,25 In adult SMCs, these PDGF isoforms
generally induce a more synthetic phenotype. For
example, PDGF-B downregulates α-SMA expression
in rat aortic SMCs.26 Similarly, PDGF-B treatment
caused contractile pig coronary artery SMC clones to
adopt a rhomboid morphology, and increased pro-
liferation and migration rates.15 These in vitro results
have been confirmed by in vivo studies showing that
inhibition of either PDGF-A or PDGF-B reduced
SMC proliferation and migration after arterial injury
in adults, leading to reduced neointima formation.27,28
TGF-β isoforms, on the other hand, appear to be
essential for the induction of the contractile SMC
phenotype. Just as PDGF isoforms, they play a role in
the migration of SMC precursors towards endothelial
cells and the subsequent interactions between them,
as revealed by TGF-β knockout mice.29 Cultured neural
crest cells differentiate towards spindle-shaped SMCs
when treated with TGF-β.30 Moreover, TGF-β1 signal-
ling has recently been shown to be required for SMC-
specific gene expression in embryoid bodies.31 In con-
trast to PDGF, TGF-β isoforms clearly promote the
contractile phenotype in adult SMCs. For example,
TGF-β1 increases α-SMA, SM-MHC and SM-calponin
levels in cultured SMCs,32 and TGF-β2 increases 
α-SMA and desmin levels in cultured porcine SMCs.15
In line with this, TGF-β induces cell cycle proteins
such as p21, which suppress cell division, and it
suppresses the degradation of matrix proteins as
reviewed elsewhere.33,34 However, TGF-β2 does not
affect expression of more advanced contractile pheno-
type markers such as SM-MHC and smoothelin.15 The
TGF-β-like factor activin A also stimulates expression
of contractile marker proteins such as α-SMA and
SM22α.35
Just as PDGF and TGF-β, retinoic acid (RA) is
required for early SMC differentiation, particularly for
neural crest-derived SMCs.36 RA treatment of em-
bryonic stem cells promotes their differentiation
towards SMCs.37 Interestingly, in adult SMCs, RA can
promote either the synthetic or the contractile SMC
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Figure 4. Factors involved in vascular SMC development, differentiation and phenotypic modulation.
phenotype, though its contractile phenotype pro-
moting effects are dominant.38 For example, expression
of contractile SMC markers including smoothelin and
SM-MHC is increased upon RA treatment,6 and most
studies indicate that retinoids decrease SMC pro-
liferation.39 In addition, RA lowers SMC migration
through induction of specific ECM proteins.40 How-
ever, CRBP-1, one of the best markers of synthetic
SMCs, is also increased upon RA treatment, and it has
been reported that retinoids stimulate SMC pro-
liferation.10,39 The differential effects of RA on the SMC
phenotype are likely to be related to the initial pheno-
type of the SMCs tested. 
Several other proteins have been reported to have
differential effects on SMC phenotype, depending on
the initial phenotype. This has led to contradictory
findings concerning, for instance, the effects of TNF-α
treatment on SMC proliferation. Recently, TNF-α was
shown to have a different effect on spindle-shaped
versus epithelioid SMCs isolated from the human
saphenous vein.41 Whereas spindle-shaped SMCs
showed increased proliferation after TNF-α treatment,
epithelioid SMCs were induced to undergo apoptosis.
Similarly, angiotensin II has been shown to induce
apoptosis in epithelioid but not in spindle-shaped
SMCs isolated from the rat aorta.42 In addition, IGF-I
appears to have differential effects on SMC proliferation
and differentiation, which depend on SMC pheno-
type.43 Spindle-shaped SMCs require IGF-I signalling
for maintenance of the contractile phenotype, whereas
epithelioid SMCs increase migration and proliferation
upon IGF-I treatment. Thus, besides RA, TNF-α,
angiotensin II and IGF-I also contribute to SMC
diversity. 
Extracellular matrix components
Although the effects of soluble (growth) factors on
SMC phenotype regulation have been the focus of the
majority of studies in the past, it now seems that the
ECM in which SMCs are embedded is at least equally
important. Modulation of the SMC phenotype by
ECM components is thought to be mediated by their
binding to specific integrin receptors. The specific
integrin combinations that are important in this respect
have been reviewed by Moiseeva.16
Most of the medial ECM is made up of collagen
isoforms (mostly type I and III), elastin, and proteo-
glycans. Among those, the proteoglycan heparin has
proven to be an important ECM component for the
regulation of SMC phenotype. Heparin generally pro-
motes the maintenance of a contractile phenotype and
slows down SMC proliferation. For example, heparin
treatment of porcine SMCs inhibits proliferation
irrespective of their phenotype and increases desmin
levels of spindle-shaped porcine SMCs.15 However
heparin decreases proliferation of bovine rhomboid
SMCs only,18 suggesting that its effects may be in-
fluenced by innate SMC phenotype characteristics.
Perlecan, another proteoglycan, appears to inhibit
SMC proliferation through its heparan sulphate side
chains, which have been suggested to sequester 
FGF-2.44 Interestingly, the expression of perlecan is
negatively regulated by PDGF isoforms, which affects
SMC migration.45
Other ECM components also provide good
examples of the complex relation between ECM com-
position and SMC phenotype. Fibrillar collagen type
I has been shown to promote the contractile phenotype
of SMCs, whereas monomeric collagen type I activates
SMC proliferation. When comparing SMCs cultured
on either monomeric or polymerised collagen, com-
pletely different gene expression profiles are observed.46
Many of these differentially expressed genes code for
ECM or cytoskeletal proteins, and several of these
genes are also up- or downregulated after balloon
injury of the rat carotid artery. Also, the different forms
of collagen type I modulate the responsiveness of
SMCs to PDGF-B.47 Moreover, the composition of
the collagen fibrils influences the migration properties
of the SMCs, which is associated with a different focal
adhesion composition and integrin function.48
Just as fibrillar collagen type I, collagen type IV and
laminin have been shown to promote the contractile
phenotype.49 However, laminin-5 was also reported to
enhance PDGF-B-stimulated SMC proliferation and
migration,50 providing another example of a protein
with ambiguous effects on SMC phenotype. Interest-
ingly, expression of this protein is upregulated by both
TGF-β and PDGF-B,50 which may explain its variable
effects. 
Whereas most ECM proteins seem to be required
for induction or maintenance of the contractile
phenotype, fibronectin, another major ECM protein,
stimulates modulation towards the synthetic pheno-
type.51 Hyaluronan, a glycosaminoglycan which is
present in the medial ECM, has also been shown to en-
hance proliferation and migration of SMCs.52 More-
over, overexpression of hyaluronan by mouse SMCs
accelerates the progression of atherosclerosis,53 which
is associated with SMC phenotypic modulation
towards the synthetic phenotype. 
Not only the composition, but also the organisation
of the ECM modulates SMC phenotype. This becomes
clear in 3D culture systems, which are a better re-
presentation of the in vivo situation than conventional
2D systems. SMCs in a 3D collagen matrix are less
proliferative compared with SMCs cultured on a 2D
collagen matrix, and have increased TGF-β1 expres-
sion.54 On the other hand, α-SMA levels are slightly
diminished and collagen I expression is higher in the
3D system, indicating a less contractile phenotype and
illustrating the complexity of the effects of the ECM
on SMC phenotype. In addition, SMC responses to
PDGF-B, TGF-β1 and heparin are affected by the
organisation of the ECM.55
Taken together, the summarised studies indicate that
both composition and organisation of the ECM have
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major consequences for SMC phenotype. Because of
the great number of ECM compounds and the various
integrin combinations that mediate the phenotypic
changes, much work remains to be done to understand
the complex effects of the ECM on SMC phenotype
in vivo. Moreover, it should be considered that the
ECM is a reservoir of cytokines and growth factors
that are bound to specific ECM components. As a
consequence, changes in the ECM composition or
volume directly affect the bioavailability of these factors
and add another dimension to the interaction between
biochemical and extracellular matrix components in
the regulation of SMC phenotype.
Physical factors
Vascular SMCs continuously encounter mechanical
stimuli that have important effects on their phenotype,
for example by changing the nature of cell-cell inter-
actions. Pressure causes stretch (tensile stress) and flow
causes shear stress, which both induce vessel wall re-
modelling by changing SMC characteristics. 
The effects of shear stress are mediated by the
endothelium, which coordinates the response of SMCs
to this type of mechanical stress. This occurs not only
through NO release, but likely also via direct cell-cell
interactions. It has been shown that upon coculturing
adult endothelial cells with adult spindle-shaped
porcine SMCs, the latter modulate towards a synthetic
phenotype. They acquire a rhomboid morphology,
reduce α-SMA and SM-MHC expression, and lose
smoothelin expression.15 However, it is obvious that
the normal physical and biochemical interactions
between SMCs and endothelial cells are difficult to
mimic in culture. 
In contrast to endothelium-modulated shear stress,
stretch acts directly on the SMCs. Mechanical forces
appear to enhance the expression of both ECM and
contractile proteins by SMCs in the vessel wall. Upon
application of physiological mechanical strain on adult
aortic SMCs, collagen and fibronectin synthesis as well
as matrix degrading enzyme levels increase, eventually
resulting in build-up of ECM.56 This indicates that
mechanical strain is a causal factor in active remodelling
of the vessel wall by SMCs. 
It is clear that through their function in the trans-
duction of mechanical stress, integrins are important
integrators of the physical factors that affect SMC
phenotype. Considering the importance of matrix-
integrin interactions for the activation of signal trans-
duction pathways that regulate SMC phenotype,
changes in ECM composition are likely to be of major
significance for the SMC response to mechanical
stimuli. Indeed, the application of cyclic mechanical
strain on neonatal rat SMCs had differential effects on,
for example, SM-MHC expression, depending on the
type of ECM substrate on which they were cultured.57
The response of adult SMCs was, however, not de-
pendent on the type of matrix. In another study,
mechanical strain applied to SMCs grown on laminin
caused a greater increase in h-caldesmon when com-
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Figure 5. SMC differentiation pathways. SMC precursors first differentiate towards naive SMCs, which have a synthetic phenotype. The large
majority of SMCs subsequently acquire a more contractile phenotype, although the extent of contractile differentiation differs and many
cells retain a phenotype between synthetic and contractile. Both differentiated synthetic and differentiated contractile SMCs can reversibly
change their phenotype via phenotypic modulation.
pared with SMCs grown on collagen type I or IV.58 The
signal transduction pathways that are activated by
stretch and shear stress59 have also been shown to
increase expression of SM-MHC.60
Similar to the various effects reported on SMC
marker gene expression, conflicting data exist on the
growth response of SMCs to mechanical strain in
culture. Both increased and reduced proliferation have
been reported.61,62 This can probably be attributed to
differences in the degree and characteristics of the
stretch that was applied and the initial phenotype of the
cells. Thus, these contradictory findings may actually
reflect both the intrinsic SMC diversity as well as the
diversity caused by a different local environment.
All in all, mechanical stress clearly has a major im-
pact on SMC phenotype. It appears that physiological
stress promotes the contractile SMC phenotype,
whereas over- or under-stressing provokes modulation
towards the synthetic phenotype. However, the in vitro
studies that are required to test this hypothesis are
hampered by the lack of a defined system that mimics
the stretch encountered in vivo. 
Conclusion
Although it is often assumed that SMCs uniformly
differentiate to a contractile phenotype, the evidence
summarised above clearly shows that SMC differenti-
ation can produce various phenotypes intermediate to
the synthetic and contractile ones. Whereas contractile
SMCs are in the majority, synthetic SMCs in the
normal vessel wall are necessary for maintenance and
physiological remodelling. Both contractile and syn-
thetic SMCs can thus be considered differentiated cells,
albeit that they have distinct functions. Consequently,
the traditional model depicting SMC differentiation
as a process in which a SMC precursor first becomes
a synthetic SMC before turning into a contractile SMC
needs complementation. 
We suggest that a basal differentiation programme
is responsible for the development of a ‘naive SMC’,
which is characterised by the expression of α-SMA,
the least phenotype-specific SMC marker. Further dif-
ferentiation, which is also (epi)genetically programmed,
can bring about synthetic or contractile, as well as
intermediate phenotypes (figure 5). These initial
phenotypes are subjected to influences (forces or
factors) of the local environment, which then de-
termine modulation within the range set by the initial
(epi)genetic programming (figure 3). 
As a result, every blood vessel has a different com-
position, consisting of SMCs that are able to fulfil
distinct complementary functions. The ability of those
SMCs to change their properties by phenotypic modu-
lation assures that each vessel can adapt to chronic
changes in the local conditions. As such, SMC diversity
does not compromise the performance of the vessel
but rather gives it the flexibility that is needed to per-
form in different physiological or pathological
situations. 
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